Rahat Warraich PhD (@rahatheart1) 's Twitter Profile
Rahat Warraich PhD

@rahatheart1

Researcher - cardiomyopathies, heart failure, immunology of cardiovascular disease and an educator.

ID: 4856978189

calendar_today28-01-2016 12:10:09

57,57K Tweet

10,10K Takipçi

2,2K Takip Edilen

Ritu Thamman MD (@iamritu) 's Twitter Profile Photo

5 Abnormal septum motion patterns on #echofirst that are nonischemic Bijoy Khandheria bit.ly/3skTxa7 1.LBBB septal flash-apical rocking 🔺LV apex moves t/w RV due to early septal shortening & posterolateral stretch 🔺delayed posterolateral contraction leads to

Sanjay Kaul (@kaulcsmc) 's Twitter Profile Photo

61% voted to downgrade or retire beta-blocker recommendation and 39% to wait for additional evidence from ongoing trials 👇 x.com/kaulcsmc/statu… For deeper dive into current evidentiary support (or lack thereof) 👇 jacc.org/doi/10.1016/j.… JACC Journals John Mandrola, MD Andrew Foy

Ritu Thamman MD (@iamritu) 's Twitter Profile Photo

Who develops ⬇️LVEF during exercise despite No CAD or a hypertensive response? Are they an early subphenotype of HFpEF? Mayo Clinic CV📝finds pts(3/4 women)w SOB/CP & exercise-induced ⬇️in LVEF w WMA (in 4/5)on ESE & NO CAD have high incidence of HF🏥& AF bit.ly/3FwR4jB

Who develops ⬇️LVEF during exercise despite No CAD or a hypertensive response? 
Are they an early subphenotype of HFpEF?
<a href="/MayoClinicCV/">Mayo Clinic CV</a>📝finds pts(3/4 women)w SOB/CP &amp; exercise-induced ⬇️in LVEF w WMA (in 4/5)on ESE &amp; NO CAD have high incidence of HF🏥&amp; AF bit.ly/3FwR4jB
Jason H. Wasfy, M.D. (@jasonwasfy) 's Twitter Profile Photo

“There’s no reason why outcomes should be getting worse,” lead author Jason H. Wasfy, MD , told TCTMD. “There are new drugs available every year. There are new procedures available. So, why should outcomes be getting worse? It suggests something wrong with the healthcare system.”

Ahmed Bennis (@drbennisahmed) 's Twitter Profile Photo

The role of finerenone in the concomitant management of CKD-type 2 diabetes and the implication for HF prevention and treatment finerenone presents new evidence-based therapy for HFpEF/HFmrEF in addition to current application in CKD associated with T2D link.springer.com/article/10.100…

The role of finerenone in the concomitant management of CKD-type 2 diabetes and the implication for HF prevention and treatment

finerenone presents new evidence-based therapy for HFpEF/HFmrEF in addition to  current application in CKD associated with T2D

link.springer.com/article/10.100…
Zurich Heart House (ZHH) (@zhh_ch) 's Twitter Profile Photo

📢Postgraduate Course in Periprocedural Echocardiography | 19.06 - 21.06.2025, London. 📢 👇 👇 👇 Learn - Network - Earn Credits REGISTER NOW: zhh.ch/en/agenda/post… Check out the foreword video by Prof. CardioTomLuscher president of European Society of Cardiology youtu.be/1-olcvQNQUA?si… Zurich Heart House (ZHH)

Victor Dayan (@victordayan1) 's Twitter Profile Photo

Great paper published by Singh and Less-Is-More Cardiologist et al. The authors evaluate predictors of angina relief separately in MED and REV treated groups. Important take home messages…. ahajournals.org/doi/full/10.11…

أنس الشريف Anas Al-Sharif (@anasalsharif0) 's Twitter Profile Photo

الناشطة العالمية غريتا تونبرغ من على متن سفينة "مادلين" المتوجهة إلى غزة: "أنا مستعدة لأقدّم حياتي مقابل 100 كيلوغرام من الدقيق لأهالي غزة".

الناشطة العالمية غريتا تونبرغ من على متن سفينة "مادلين" المتوجهة إلى غزة:
"أنا مستعدة لأقدّم حياتي مقابل 100 كيلوغرام من الدقيق لأهالي غزة".
Nicolas Merke (@nmerke) 's Twitter Profile Photo

#echofirst needs to give Surgeons and interventional cardiologist correct diagnosis, therefore we need to know how to apply what Guidelines do recommend, PISA EROA is part of the tool box Make your numbers plausible and know the pitfalls 🫵shorturl.at/EUUSH